ISSCA Paraguay 2026 | March 19–20, 2026 | Sheraton Asunción Hotel
Asunción, Paraguay — The International Society for Stem Cell Application (ISSCA) announces the International Congress in Regenerative Medicine — ISSCA Paraguay 2026, to be held on March 19–20, 2026, at the Sheraton Asunción Hotel. The congress represents a historic step for Paraguay’s medical community, as the country experiences growing demand for innovative therapies, updated clinical standards, and access to formal training in regenerative and peptide-based medicine.
In recent years, Paraguay has seen an increase in private clinics, wellness centers, and cross-border patients seeking advanced treatments. However, as in many emerging markets, access to standardized education, validated protocols, and international certification remains limited. ISSCA’s arrival directly addresses this gap by offering physicians high-level scientific content and hands-on clinical training aligned with global standards.
“Paraguay is entering a defining moment in its medical modernization,” said Benito Novas, Founder of ISSCA.
“We are witnessing a strong regional interest in regenerative and peptide-based therapies, but physicians need the right scientific foundation and clinical structure to implement them safely. Bringing ISSCA’s certifications to Paraguay means empowering local doctors with the same quality of training offered in the most developed medical centers in the world.”
A Strategic Event for Paraguay’s Medical Growth
The congress arrives at a time when physicians in Paraguay are increasingly integrating functional medicine, aesthetic regeneration, longevity treatments, and minimally invasive protocols into their practices. Yet, the country still faces challenges:
- Limited access to updated international training
- Few local programs dedicated to regenerative medicine
- Growing patient demand for safe, scientifically backed therapies
- The need for clinical standardization and regulation
ISSCA Paraguay aims to bridge these gaps by providing a platform for education, transformation, and professionalization of regenerative medicine across the country.
Scientific Program: A Forward-Looking Perspective for Paraguay
The event will feature forward-looking sessions on:
- Cellular therapies and clinical applications
- The emerging role of peptides in personalized medicine
- Regenerative aesthetics and tissue optimization
- Longevity, metabolism, and inflammation control
- Musculoskeletal repair and sports performance
Clinical Certifications Offered in Paraguay
1. ISSCA Flagship Certification in Regenerative Medicine
A foundational and advanced program designed to establish clinical competency in cellular and regenerative therapies.
2. ISSCA Certification in Peptide Therapy
A specialized certification focused on the application of bioactive peptides for longevity, metabolic regulation, immune balance, hormonal support, and performance optimization.
These certifications represent a significant advancement for the country, providing Paraguayan physicians with training previously accessible only in larger medical hubs across North America, Europe, and the Middle East.
MedConnect Paraguay: Building Professional Bridges Across Latin America
MedConnect Paraguay will serve as a strategic networking forum designed to connect local physicians with an international community of clinicians, researchers, and innovators.
In an engaging and professional environment, attendees will be able to:
- Build meaningful connections with colleagues across Latin America
- Discuss real clinical cases and share field experiences
- Explore collaborative opportunities in research and practice
- Gain insights into emerging medical trends before they reach mass adoption
MedConnect is one of ISSCA’s most valued components, fostering a community that supports long-term professional growth.
Why ISSCA’s Arrival Matters for Paraguay
ISSCA’s presence in Paraguay represents a pivotal opportunity for the country’s medical development:
- Professionalization of regenerative medicine through internationally standardized education
- Improved patient safety via structured, evidence-based clinical training
- Greater access to emerging therapies, including peptides, exosomes, and cellular science
- Strengthening of Paraguay’s role in regional medical tourism
- Integration into global scientific networks, connecting physicians with leaders and innovators worldwide
- Acceleration of clinical modernization, enabling local practices to evolve with the future of medicine
ISSCA Paraguay 2026 is not just an event—it is a catalyst for elevating the country’s medical capabilities.
👉 Register Now
www.issca.com
Exclusive benefits include:
- Early-bird pricing
- Priority access to certification seats
- Invitation to the MedConnect networking event
- Access to pre-event webinars and educational resources
About ISSCA
“The International Society for Stem Cell Application (ISSCA) is a leading organization in the field of regenerative medicine. It is dedicated to advancing the science and practice of stem cell therapy and regenerative medicine through education, certification, research, and training. ISSCA provides certification training in cities worldwide, recognizing the importance of standards and certifications in regenerative medicine as a medical specialty.”
About Global Stem Cells Group
“Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare.”
Safe Harbor Statement
Statements in this news release may be “forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business, partly based on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
